You're right. Our particular pack of shorts are he
Post# of 147645
Their overriding goal is to keep this drug and this company as out of public awareness as possible, thus keeping the volume down. Without low volume they are screwed. JL knows this, thus his multifront campaign to loft leronlimab and CytoDyn into the respectibility they deserve. Get papers out there, get studies running, get licensure/partnership agreements inked. I'm betting on him.